Ropri, A. S., Lam, T. G., Kalia, V., Buchanan, H. M., Bartosch, A. M. W., Youth, E. H. H., Xiao, H., Ross, S. K., Jain, A., Chakrabarty, J. K., Kang, M. S., Boyett, D., Spinazzi, E. F., Iodice, G., McGovern, R. A., Honig, L. S., Brown, L. M., Miller, G. W., McKhann, G. M., & Teich, A. F. (2024). Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14194

Damuka, N., Irmen, R. E., Krizan, I., Miller, M., Gollapelli, K. K., Bhoopal, B., Deep, O., Bansode, A., Lockhart, S. N., Orr, M. E., Jadiya, P., Bashetti, N., Kumar, J. V. S., Mintz, A., Whitlow, C. T., Craft, S., Macauley, S. L., & Solingapuram Sai, K. K. (2024). Exploring microtubule dynamics in Alzheimer’s disease: Longitudinal assessment using [11C]MPC‐6827 PET imaging in rodent models of Alzheimer’s‐related pathology. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14083

Kim, H., Lee, S., Levine, A., Huber, B., Andrews, H., Kerner, N. A., Cohen, D., Carlson, S., Bell, S. A., Rivera, A. M., Gordon, M. L., Simoes, S., Devanand, Davangere. P., Brickman, A. M., Schneider, L. S., Harvey, P. D., & Goldberg, T. E. (2024). Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.13757

Mares, J., Costa, A. P., Dartora, W. J., Wartchow, K. M., Lazarian, A., Bennett, D. A., Nuriel, T., Menon, V., & McIntire, L. B. J. (2024). Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with APOEε4 and mild cognitive impairment. Frontiers in Aging Neuroscience, 16. https://doi.org/10.3389/fnagi.2024.1419253

Feldman, H. H., Luchsinger, J. A., Léger, G. C., Taylor, C., Jacobs, D. M., Salmon, D. P., Edland, S. D., Messer, K., Revta, C., Flowers, S. A., Jones, K. S., Koulman, A., Yarasheski, K. E., Verghese, P. B., Venkatesh, V., Zetterberg, H., Durant, J., Lupo, J.-L., & Gibson, G. E. (2024). Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam). PLOS ONE, 19(5), e0302998. https://doi.org/10.1371/journal.pone.0302998

Wang, H.-P., Scalco, R., Saito, N., Beckett, L., Nguyen, M.-L., Huie, E. Z., Honig, L. S., DeCarli, C., Rissman, R. A., Teich, A. F., Mungas, D. M., Jin, L.-W., & Dugger, B. N. (2024). The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease. Acta Neuropathologica Communications, 12(1). https://doi.org/10.1186/s40478-024-01773-4

Oveisgharan, S., Yu, L., de Paiva Lopes, K., Petyuk, V. A., Tasaki, S., Vialle, R., Menon, V., Wang, Y., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2024). G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults. Communications Biology, 7(1). https://doi.org/10.1038/s42003-024-06272-9

Al-Dalahmah, O., Lam, M., McInvale, J. J., Qu, W., Nguyen, T., Mun, J.-Y., Kwon, S., Ifediora, N., Mahajan, A., Humala, N., Winters, T., Angeles, E., Jakubiak, K. A., Kühn, R., Kim, Y. A., De Rosa, M. C., Doege, C. A., Paryani, F., Flowers, X., … Hargus, G. (2024). Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons. Cell Stem Cell, 31(5), 676-693.e10. https://doi.org/10.1016/j.stem.2024.03.013

Bhattarai, P., Gunasekaran, T. I., Belloy, M. E., Reyes-Dumeyer, D., Jülich, D., Tayran, H., Yilmaz, E., Flaherty, D., Turgutalp, B., Sukumar, G., Alba, C., McGrath, E. M., Hupalo, D. N., Bacikova, D., Le Guen, Y., Lantigua, R., Medrano, M., Rivera, D., Recio, P., … Vardarajan, B. N. (2024). Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-024-02721-1

Jiang, S., Sydney, E. J., Runyan, A. M., Serpe, R., Srikanth, M., Figueroa, H. Y., Yang, M., & Myeku, N. (2024). 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy. Frontiers in Cellular Neuroscience, 18. https://doi.org/10.3389/fncel.2024.1338502

Oka, T., Matsuzawa, Y., Tsuneyoshi, M., Nakamura, Y., Aoshima, K., Tsugawa, H., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Saykin, A. J., Morris, J., Shaw, L. M., … Liu, E. (2024). Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-56837-1

Wang, G., Li, Y., Xiong, C., Benzinger, T. L. S., Gordon, B. A., Hassenstab, J., Aschenbrenner, A. J., McDade, E., Clifford, D. B., Libre‐Guerra, J. J., Shi, X., Mummery, C. J., van Dyck, C. H., Lah, J. J., Honig, L. S., Day, G., Ringman, J. M., Brooks, W. S., … Fox, N. C. (2024). Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer’s disease. Alzheimer’s & Dementia, 20(4), 2698–2706. Portico. https://doi.org/10.1002/alz.13735

Xicota, L., Cosentino, S., Vardarajan, B., Mayeux, R., Perls, T. T., Andersen, S. L., Zmuda, J. M., Thyagarajan, B., Yashin, A., Wojczynski, M. K., Krinsky‐McHale, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M. E., Schupf, N., Lee, J. H., & Barral, S. (2024). Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer’s disease. Alzheimer’s & Dementia, 20(4), 2670–2679. Portico. https://doi.org/10.1002/alz.13718

Joseph‐Mathurin, N., Feldman, R. L., Lu, R., Shirzadi, Z., Toomer, C., Saint Clair, J. R., Ma, Y., McKay, N. S., Strain, J. F., Kilgore, C., Friedrichsen, K. A., Chen, C. D., Gordon, B. A., Chen, G., Hornbeck, R. C., Massoumzadeh, P., McCullough, A. A., Wang, Q., … Li, Y. (2024). Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage. Alzheimer’s & Dementia, 20(4), 2680–2697. Portico. https://doi.org/10.1002/alz.13729

Rossano, S. M., Johnson, A. S., Smith, A., Ziaggi, G., Roetman, A., Guzman, D., Okafor, A., Klein, J., Tomljanovic, Z., Stern, Y., Brickman, A. M., Lee, S., Kreisl, W. C., & Lao, P. (2024). Microglia measured by TSPO PET are associated with Alzheimer’s disease pathology and mediate key steps in a disease progression model. Alzheimer’s & Dementia, 20(4), 2397–2407. Portico. https://doi.org/10.1002/alz.13699

Yu, Q., Du, F., Belli, I., Gomes, P. A., Sotiropoulos, I., & Waites, C. L. (2024). Glucocorticoid stress hormones stimulate vesicle-free Tau secretion and spreading in the brain. Cell Death & Disease, 15(1). https://doi.org/10.1038/s41419-024-06458-3

Telpoukhovskaia, M. A., Murdy, T. J., Marola, O. J., Charland, K., MacLean, M., Luquez, T., Lish, A. M., Neuner, S., Dunn, A., Onos, K. D., Wiley, J., Archer, D., Huentelman, M. J., Arnold, M., Menon, V., Goate, A., Van Eldik, L. J., Territo, P. R., … Howell, G. R. (2024). New directions for Alzheimer’s disease research from the Jackson Laboratory Center for Alzheimer’s and Dementia Research 2022 workshop. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(1). Portico. https://doi.org/10.1002/trc2.12458

Hojjati, S. H., Chiang, G. C., Butler, T. A., de Leon, M., Gupta, A., Li, Y., Sabuncu, M. R., Feiz, F., Nayak, S., Shteingart, J., Ozoria, S., Gholipour Picha, S., Stern, Y., Luchsinger, J. A., Devanand, D. P., & Razlighi, Q. R. (2024). Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent. Journal of Alzheimer’s Disease, 98(4), 1467–1482. https://doi.org/10.3233/jad-231362

Hayden, K. M., Mielke, M. M., Evans, J. K., Neiberg, R., Molina-Henry, D., Culkin, M., Marcovina, S., Johnson, K. C., Carmichael, O. T., Rapp, S. R., Sachs, B. C., Ding, J., Shappell, H., Wagenknecht, L., Luchsinger, J. A., & Espeland, M. A. (2024). Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer’s and Related Dementias in the Look AHEAD Cohort. The Journal of Aging Research & Lifestyle. https://doi.org/10.14283/jarlife.2024.1

Honig, L. S., Kang, M. S., Sanchez, D., Reyes‐Dumeyer, D., Lantigua, R. A., Dage, J. L., Brickman, A. M., Manly, J. J., Mayeux, R., & Gu, Y. (2023). Longitudinal change of plasma biomarkers with incident mild cognitive impairment or Alzheimer’s disease in a multi‐ethnic cohort. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.080615

Hojjati, S. H., Feiz, F., Nayak, S., Shteingart, J., Ozoria, S., Picha, S. G., Fernández, A., Devanand, D. P., Luchsinger, J. A., Stern, Y., & Razlighi, Q. R. (2023). Hub brain regions for the remote spatial association between tau and Amyloid‐β proteins. Alzheimer’s & Dementia, 19(S16). Portico. https://doi.org/10.1002/alz.076456

Johnson, A. S., Ziaggi, G., Smith, A. C., Guzmán, D. S., Okafor, A., Huey, E. D., Kreisl, W. C., Talmasov, D., & Lao, P. J. (2023). Elevated Tau burden in Amygdala and Hippocampus amongst older participants with psychosis. Alzheimer’s & Dementia, 19(S10). Portico. https://doi.org/10.1002/alz.081869

Ma, Y., Chen, K. W., Fujita, M., Yu, L., Menon, V., Schneider, J. A., Bennett, D. A. A., & De Jager, P. L. (2023). Cataloging the role of brain cell types on suppressing the effect of APOE ε4 on Alzheimer’s disease risk. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.077046

Mehta, N. H., Zhou, L., Li, Y., McIntire, L. B., Nordvig, A., Butler, T., de Leon, M., & Chiang, G. C. (2023). Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-34012-2

Johnson, A. S., Zou, J., Smith, A. C., Okafor, A., Guzmán, D. S., Kreisl, W. C., Brickman, A. M., Luchsinger, J. A., & Lao, P. J. (2023). Discovering correlates of off‐target 18F‐MK6240 signal in community‐dwelling adults. Alzheimer’s & Dementia, 19(S10). Portico. https://doi.org/10.1002/alz.081866

Johnson, A. S., Zou, J., Smith, A. C., Okafor, A., Guzm, D. S., Kreisl, W. C., Brickman, A. M., Luchsinger, J. A., & Lao, P. J. (2023). Discovering correlates of off‐target 18F‐MK6240 signal in community‐dwelling adults. Alzheimer’s & Dementia, 19(S16). Portico. https://doi.org/10.1002/alz.079013

Bahl, A., Honig, L. S., Kang, M. S., Sanchez, D., Reyes‐Dumeyer, D., Lantigua, R. A., Dage, J. L., Brickman, A. M., Manly, J. J., Mayeux, R., & Gu, Y. (2023). Plasma‐based biomarkers of Alzheimer’s Disease in a multi‐ethnic population: A Cross‐Sectional analysis from the WHICAP Study. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.080443

Kalia, V., Reyes‐Dumeyer, D., Dubey, S., Nandakumar, R., Lee, A. J., Lantigua, R. A., Medrano, M., Mejia, D. R., Recio, P., Honig, L. S., Mayeux, R., Miller, G. W., & Vardarajan, B. N. (2023). Metabolites correlate with plasma biomarkers and clinical diagnosis of Alzheimer’s Disease. Alzheimer’s & Dementia, 19(S15). Portico. https://doi.org/10.1002/alz.078516

Rios, A. M., Chen, C. W., Jacotot, E. D., & Troy, C. M. (2023). Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease. Alzheimer’s & Dementia, 19(S21). Portico. https://doi.org/10.1002/alz.077194

Clifton, M., Seto, M., Buckley, R. F., Gifford, K. A., Jefferson, A. L., De Jager, P. L., Bennett, D. A. A., Barnes, L. L., Wang, Y., Schneider, J. A., Hohman, T. J., & Dumitrescu, L. C. (2023). Sex‐specific associations of gene expression in brain with Alzheimer’s disease pathology and cognitive performance. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.079096

Kim, H. J., Lane, K. A., Gao, S., Hammers, D. B., Logan, P. E., Aisen, P. S. S., Dage, J. L., Eloyan, A., Foroud, T. M., Grinberg, L. T., Iaccarino, L., Jack, C. R., Kramer, J. H., Koeppe, R. A., Kukull, W. A., La Joie, R., Mundada, N. S., Murray, M. E., Nudelman, K. N. H., … Apostolova, L. G. (2023). Cognitive Clusters of Early‐onset non‐Alzheimer’s disease. Alzheimer’s & Dementia, 19(S24). Portico. https://doi.org/10.1002/alz.083061

Nashman, Z., Runyan, A., Sydney, E., & Myeku, N. (2023). Modulation of the Immunoproteasome Affects Pathological Tau Aggregation in Alzheimer’s Disease. Alzheimer’s & Dementia, 19(S13). Portico. https://doi.org/10.1002/alz.071413

Elyaman, W. (2023). CNS Immune Surveillance in Alzheimer’s Disease. Alzheimer’s & Dementia, 19(S13). Portico. https://doi.org/10.1002/alz.070853

Scalco, R., Saito, N., Beckett, L., Nguyen, M.-L., Huie, E., Wang, H.-P., Flaherty, D. A., Honig, L. S., DeCarli, C., Rissman, R. A., Teich, A. F., Jin, L.-W., & Dugger, B. N. (2023). The neuropathological landscape of Hispanic and non-Hispanic White decedents with Alzheimer disease. Acta Neuropathologica Communications, 11(1). https://doi.org/10.1186/s40478-023-01574-1

Johnson, A. S., Ziaggi, G., Smith, A. C., Guzmán, D. S., Okafor, A., Huey, E. D., Kreisl, W. C., Talmasov, D., & Lao, P. J. (2023). Elevated Tau burden in Amygdala and Hippocampus amongst older participants with psychosis. Alzheimer’s & Dementia, 19(S18). Portico. https://doi.org/10.1002/alz.079051

Qiao, M. N., Reyes‐Dumeyer, D., Medrano, M., Lantigua, R. A., Mayeux, R., & Vardarajan, B. N. (2023). Protective variants in Alzheimer’s Disease from healthy elderly APOE‐ε4 participants. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.080360

Jain, L., Khrestian, M., Formica, S., Tuason, E. D., Pillai, J. A., Rao, S. M., Oguh, O., Lippa, C., Lopez, O. L., Berman, S., Tsuang, D. W., Zabetian, C. P., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K., Honig, L. S., Fleisher, J. E., Galvin, J. E., … Bekris, L. M. (2023). ATN Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies: Initial Results from the United States Dementia with Lewy Bodies Consortium. Alzheimer’s & Dementia, 19(S21). Portico. https://doi.org/10.1002/alz.077443

Contreras, A. G., Walters, S., Mukherjee, S., Lee, M. L., Choi, S., Scollard, P., Trittschuh, E. H., Mez, J. B., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Widaman, K. F., Buckley, R., Mormino, E. C., Kunkle, B. W., Naj, A. C., Clark, L. R., … Gifford, K. A. (2023). APOE4‐stratified GWAS across cognitive domains in non‐Hispanic white and non‐Hispanic black individuals. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.080317

Sudhakar, T. D., Levendovszky, S. R., Zabetian, C. P., Tsuang, D. W., Pillai, J. A., Rao, S. M., Oguh, O., Lippa, C., Lopez, O. L., Berman, S., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K., Honig, L. S., Fleisher, J. E., Galvin, J. E., Bozoki, A., Taylor, A., … Olson, V. (2023). Identification of Hippocampal and Amygdala Subfields Predictive of MoCA Scores in Patients with Dementia with Lewy Bodies. Alzheimer’s & Dementia, 19(S24). Portico. https://doi.org/10.1002/alz.082764

Lee, A. J., Reyes‐Dumeyer, D., De Jager, P. L., Bennett, D. A. A., Schneider, J. A., Menon, V., Wang, Y., Lantigua, R. A., Medrano, M., Mejia, D. R., Jiménez‐Velázquez, I. Z., Kukull, W. A., Brickman, A. M., Manly, J. J., Tosto, G., Kizil, C., Farrer, L. A., Mez, J. B., Chung, J., … Mayeux, R. (2023). Multi‐ethnic genome‐wide, gene‐based study identifies genes that interact with vascular risk factors in Alzheimer’s Disease (AD). Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.079970

Leeuw, S. M., Putter, J., van der Kant, R., & Nuriel, T. (2023). Elucidating APOE4‐dependent cholesterol dysregulation in endolysosomes related to Alzheimer’s disease biology. Alzheimer’s & Dementia, 19(S13). Portico. https://doi.org/10.1002/alz.079909

Lee, A. J., Raghavan, N. S., Bhattarai, P., Reyes‐Dumeyer, D., De Jager, P. L., Bennett, D. A. A., Schneider, J. A., Menon, V., Wang, Y., Lantigua, R. A., Medrano, M., Mejia, D. R., Jiménez‐Velázquez, I. Z., Kukull, W. A., Brickman, A. M., Manly, J. J., Tosto, G., Mayeux, R., Kizil, C., & Vardarajan, B. N. (2023). Interaction of genetic and cardiovascular risk factors identifies pathways involved in Alzheimer’s Disease. Alzheimer’s & Dementia, 19(S13). Portico. https://doi.org/10.1002/alz.073804

Yang, H.-S., Teng, L., Kang, D., Menon, V., Ge, T., Finucane, H. K., Schultz, A. P., Properzi, M., Klein, H.-U., Chibnik, L. B., Schneider, J. A., Bennett, D. A., Hohman, T. J., Mayeux, R. P., Johnson, K. A., De Jager, P. L., & Sperling, R. A. (2023). Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-43132-2

Siddiqui, T., Cosacak, M. I., Popova, S., Bhattarai, P., Yilmaz, E., Lee, A. J., Min, Y., Wang, X., Allen, M., İş, Ö., Atasavum, Z. T., Rodriguez-Muela, N., Vardarajan, B. N., Flaherty, D., Teich, A. F., Santa-Maria, I., Freudenberg, U., Werner, C., Tosto, G., … Kizil, C. (2023). Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s disease. Npj Regenerative Medicine, 8(1). https://doi.org/10.1038/s41536-023-00311-5

Laing, K. K., McQuaid, C., Lao, P. J., Chagnot, A., Stefancova, D., Garcia, D. J., Fialova, N., Brickman, A. M., Wardlaw, J. M., & Montagne, A. (2023). Apolipoprotein E Status Mediates Pericyte Recruitment Mechanisms in the Presence of Excess Cholesterol. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.078978

Whittington, A., Porat, L., Christian, B. T., Devanand, D. P., Hostetler, E. D., Johnson, K. A., Johnson, S. C., Klunk, W. E., Lao, P. J., Rowe, C. C., Devanarayan, V., Reilhac, A., Reyderman, L., Irizarry, M. C., Charil, A., & Gunn, R. N. (2023). Estimating Braak stage from [18F]MK6240 PET scans. Alzheimer’s & Dementia, 19(S24). Portico. https://doi.org/10.1002/alz.083004

Green, G. S., Yang, H., Fujita, M., Taga, M., Regev, A., Menon, V., Bennett, D. A. A., Habib, N., & De Jager, P. L. (2023). Cellular dynamics across aged human brains uncover a multicellular cascade leading to Alzheimer’s disease. Alzheimer’s & Dementia, 19(S24). Portico. https://doi.org/10.1002/alz.083212

Yang, H., Mukherjee, S., Latimer, C. S., Teng, L., White, C. C., Yu, L., Sperling, R. A., Larson, E. B., Crane, P. K., Keene, C. D., Bennett, D. A. A., Schneider, J. A., & De Jager, P. L. (2023). A genome‐wide association study of LATE‐NC (limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change) reveals a distinct genetic architecture. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.079393

Dark, H. E., Paterson, C., Daya, G. N., Peng, Z., Duggan, M. R., Bilgel, M., An, Y., Moghekar, A., Davatzikos, C., Resnick, S. M., Loupy, K., Simpson, M., Candia, J., Mosley, T., Coresh, J., Palta, P., Ferrucci, L., Shapiro, A., Williams, S. A., & Walker, K. A. (2023). Proteomic Indicators of Health Predict Alzheimer’s Disease Biomarker Levels and Dementia Risk. Annals of Neurology, 95(2), 260–273. Portico. https://doi.org/10.1002/ana.26817

Nemes, S., Logan, P. E., Manchella, M. K., Mundada, N. S., La Joie, R., Polsinelli, A. J., Hammers, D. B., Koeppe, R. A., Foroud, T. M., Nudelman, K. N., Eloyan, A., Iaccarino, L., Dorsant‐Ardón, V., Taurone, A., Thangarajah, M., Dage, J. L., Aisen, P., Grinberg, L. T., … Jack, C. R. (2023). Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early‐onset Alzheimer’s disease. Alzheimer’s & Dementia, 19(S9). Portico. https://doi.org/10.1002/alz.13403